Dr. Fauci Explains The Timeline And Risks Of Creating A COVID-19 Vaccine | MSNBC

A THOUSAND OR TWO TO A THOUSAND. Thank YOU. Thank YOU. > >! Well, DO QUESTIONS. > >! Well, DO QUESTIONS > >! Thank YOU, MR. VICE > >. Thank YOU. Mr. VICE PRESIDENT, PRESIDENT IM GOING CHANGE. The TOPIC JUST IM GOING CHANGE THE TOPIC JUST A LITTLE BIT, BECAUSE THERE WAS A LITTLE BIT BECAUSE THERE WAS A QUESTION THAT CAME UP AND IVE QUESTION THAT CAME UP AND IVE BEEN ASKED ABOUT THIS ON A BEEN ASKED ABOUT THIS ON A COUPLE OF Media INTERACTIONS, COUPLE OF MEDIA INTERACTIONS REGARDING THE INTERVENTIONS REGARDING THE INTERVENTIONS WERE TALKING ABOUT, WERE TALKING ABOUT AND ITS IMPORTANT BECAUSE ITS AND ITS IMPORTANT, BECAUSE ITS ABOUT SOMETHING THAT I SAID ABOUT SOMETHING THAT I SAID YESTERDAY ABOUT WHAT WE WOULD YESTERDAY ABOUT WHAT WE WOULD LIKELY Sees WHENEVER YOU PUT THE LIKELY SEE WHENEVER YOU PUT THE CLAMPS DOWN AND SHUT THINGS, CLAMPS DOWN AND SHUT THINGS DOWN, YOU DO IT FOR TWO REASONS DOWN YOU DO IT FOR TWO REASONS YOU DO IT TO PREVENT THE FURTHER YOU DO IT TO PREVENT THE FURTHER Spread

Spread, WE CALL MITIGATION, WE CALL MITIGATION, BUT YOU ALSO DO IT TO BUY, BUT YOU ALSO DO IT TO BUY YOURSELF TIME TO GET BETTER YOURSELF TIME TO GET BETTER PREPARED FOR WHAT MIGHT BE A PREPARED FOR WHAT MIGHT BE A REBOUND. It MAY BE A REBOUND THAT WE GET, IT MAY BE A REBOUND THAT WE GET THINGS REALLY UNDER CONTROL AND THINGS REALLY UNDER CONTROL, AND THEN YOU PULL BACK, WHICH THEN YOU PULL BACK, WHICH ULTIMATELY WAS GOING TO HAVE ULTIMATELY WAS GOING TO HAVE TO DO.

To DO NERVE THE WORLD GOING TO HAVE TO NERVE THE WORLD GOING TO HAVE TO DO THAT, DO THAT YOU EITHER GET A REBOUND OR IT YOU EITHER GET A REBOUND OR IT MIGHT CYCLE INTO THE NEXT MIGHT CYCLE INTO THE NEXT SEASON. So WHAT ARE WE GOING TO DO TO SO? What ARE WE GOING TO DO TO PREPARE OURSELVES FOR THAT PREPARE OURSELVES? For THAT ONE OF THE MOST IMPORTANT THINGS ONE OF THE MOST IMPORTANT THINGS IS ONE THAT I MENTIONED. Several IS ONE THAT I MENTIONED SEVERAL TIMES FROM THIS PODIUM:

Times FROM THIS PODIUM, AND THAT IS TO CLARIFY A BIT – AND THAT IS TO CLARIFY A BIT ABOUT THE TIMELINE FOR VACCINES, ABOUT THE TIMELINE FOR VACCINES AND WITH THAT HAVE ANY REAL AND WITH THAT HAVE ANY REAL IMPACT ON WHAT WE WOULD CALL THE IMPACT ON. What WE WOULD CALL THE REBOUNDS OR WHAT WE WOULD CALL REBOUNDS OR WHAT WE WOULD CALL THE CYCLING IN THE SEASON, THE CYCLING IN THE SEASON, CERTAINLY FOR SURE A VACCINE IS CERTAINLY FOR SURE. A VACCINE IS NOT GOING TO HELP US NOW. Next, NOT GOING TO HELP US NOW NEXT MONTH, THE MONTH AFTER MONTH, THE MONTH AFTER, BUT AS I MENTIONED TO YOU, WE BUT, AS I MENTIONED TO YOU, WE WENT INTO A PHASE. 1 TRIAL WENT INTO A PHASE 1 TRIAL AND I KEEP REFERRING TO ONE AND I KEEP REFERRING TO ONE VACCINE. There IS MORE THAN ONE THERE IS MORE THAN ONE

There IS A COUPLE OF HANDFULS OF. There IS A COUPLE OF HANDFULS OF VACCINES AT DIFFERENT STAGES OF VACCINES AT DIFFERENT STAGES OF DEVELOPMENT, BUT THEYRE ALL FOLLOWING THE BUT THEYRE ALL FOLLOWING THE SAME COURSE SAME COURSE, AND THE COURSE IS, YOU FIRST GO AND THE COURSE IS YOU FIRST GO IN TO A PHASE 1 TRIAL TO SEE IF IN TO A PHASE 1 TRIAL, TO SEE IF ITS SAFE AND YOU HAVE VERY FEW ITS SAFE AND YOU HAVE VERY FEW PEOPLE – 45 PEOPLE WITHIN A PEOPLE – 45 PEOPLE WITHIN A CERTAIN AGE GROUP, ALL HEALTHY, CERTAIN AGE GROUP, ALL Healthy, NONE AT REALLY ANY GREAT RISK OF NONE AT REALLY ANY GREAT RISK OF GETTING INFECTED.

Getting INFECTED THE REASON YOU DO THAT, BECAUSE THE REASON YOU DO THAT BECAUSE YOU WANT TO MAKE SURE THAT ITS YOU WANT TO MAKE SURE THAT ITS SAFE, SAFE AND THE NEXT THING YOU DO AND AND THE NEXT THING YOU DO AND THAT TAKES ABOUT THREE MONTHS – That TAKES ABOUT THREE MONTHS EASILY, MAYBE MORE EASILY, MAYBE MORE SO THATS GOING TO BRING SEXUAL SO THATS GOING TO BRING SEXUAL ABUSE THE BEGINNING OR MIDDLE OF ABUSE, THE BEGINNING OR MIDDLE OF THE SUMMER. The SUMMER, THEN YOU GO TO A PHASE 2 TRIAL. Then YOU GO TO A PHASE 2 TRIAL OR WHAT WE SAY: 2-3, WHICH MEANS OR WHAT WE SAY 2-3, WHICH MEANS WERE GOING TO PUT A LOT OF WERE GOING TO PUT A LOT OF PEOPLE IN THERE.

People IN THERE NOW WE HOPE THAT THERE ARENT A NOW. We HOPE THAT THERE ARENT A LOT OF PEOPLE GETTING INFECTED LOT OF PEOPLE GETTING INFECTED, BUT IT IS LIKELY THERE WILL BE, BUT IT IS LIKELY THERE WILL BE SOMEWHERE IN THE WORLD WHERE, SOMEWHERE IN THE WORLD, WHERE THATS GOING ON THATS GOING ON. So, ITS LIKELY THAT WE WILL GET SO ITS LIKELY THAT WE WILL GET WHATS CALLED AN EFFICACY. What’s CALLED AN EFFICACY SIGNAL SIGNAL AND WE WILL KNOW WHETHER OR NOT, AND WE WILL KNOW WHETHER OR NOT IT ACTUALLY WORKS IT ACTUALLY WORKS. If, IN FACT, IT DOES, WE HOPE IT IF, IN FACT IT DOES, WE HOPE IT IS ABLE TO HAVE SOME IMPACT ON IS ABLE TO HAVE SOME IMPACT ON RECYCLING IN THE NEXT SEASON RECYCLING IN THE NEXT SEASON, LIKE I SAID THAT COULD BE A LIKE. I SAID THAT COULD BE A YEAR TO A YEAR AND A HALF YEAR TO A YEAR AND A HALF IM, NOT CHANGING ANY OF THE IM, NOT CHANGING ANY OF THE DATES THAT I MENTIONED.

Dates THAT I MENTIONED, BUT ONE OF THE THINGS THAT WE BUT ONE OF THE THINGS THAT WE ARE GOING TO DO, THAT YOU NEED TO BE GOING TO DO THAT. You NEED TO UNDERSTAND THAT HAS BEEN A UNDERSTAND. That HAS BEEN A STUMBLING BLOCK FOR PREVIOUS STUMBLING BLOCK FOR PREVIOUS DEVELOPMENT OF VACCINES AND DEVELOPMENT OF VACCINES, AND THAT IS EVEN BEFORE YOU KNOW THAT IS EVEN BEFORE YOU KNOW SOMETHING WORKS AT RISK. You SOMETHING WORKS AT RISK. You HAVE TO START PRODUCING, IT HAVE TO START PRODUCING IT, BECAUSE ONCE YOU KNOW IT WORKS BECAUSE ONCE YOU KNOW IT WORKS, YOU CANT SAY GREAT: IT WORKS, YOU CANT, SAY GREAT. It WORKS NOW. Give ME ANOTHER SIX MONTHS NOW GIVE ME ANOTHER SIX MONTHS TO PRODUCE IT TO PRODUCE IT SO WERE WORKING WITH A VARIETY, SO WERE IS WORKING WITH A VARIETY OF COMPANIES TO TAKE THAT RISK OF COMPANIES TO TAKE THAT RISK, WE DIDNT TAKE IT WITH ZIKA

We DIDNT TAKE IT WITH ZIKA. We HAVE A NICE ZIKA VACCINE, BUT WE HAVE A NICE ZIKA VACCINE, BUT WE DONT HAVE ENOUGH TO DO IT. We DONT HAVE ENOUGH TO DO IT BECAUSE WE DONT HAVE ENOUGH, BECAUSE WE DONT HAVE ENOUGH ZIKA AROUND ZIKA AROUND THE SAME WITH SARS, THE SAME WITH SARS THATS ONE OF THE THINGS WERE THATS. One OF THE THINGS WERE REALLY GOING TO BE ABLE TO PUSH REALLY GOING TO BE ABLE TO PUSH ON IS TO HAVE IT READY IN CASE ON IS TO HAVE IT READY IN CASE IT WORKS. It WORKS NOW. The ISSUE OF SAFETY. Now, THE ISSUE OF SAFETY, SOMETHING I WANT TO MAKE SURE SOMETHING. I WANT TO MAKE SURE THAT THE AMERICAN PUBLIC, THAT THE AMERICAN PUBLIC UNDERSTAND ITS NOT ONLY SAFETY WHEN YOU ITS NOT ONLY SAFETY WHEN YOU INJECT SOMEBODY AND THEY GET INJECT SOMEBODY AND THEY GET. Maybe, AN IDIOSYNCRATIC REACTION, MAYBE AN IDIOSYNCRATIC REACTION. They GET A LITTLE ALLERGIC, THEY GET A LITTLE ALLERGIC REACTION. They GET PAIN.

Reaction, THEY GET PAIN, THERE IS SAFETY ASSOCIATED. Does THERE IS SAFETY ASSOCIATED? Does THE VACCINE MAKE YOU WORSE? The VACCINE MAKE YOU WORSE AND THERE ARE DISEASES IN WHICH – AND THERE ARE DISEASES IN WHICH YOU VACCINATE SOMEONE. They GET YOU VACCINATE SOMEONE THEY GET INFECTED WITH. What YOURE TRYING INFECTED WITH WHAT YOURE TRYING TO PROTECT THEM WITH AND YOU TO PROTECT THEM WITH, AND YOU ACTUALLY ENHANCE THE INFECTION, ACTUALLY ENHANCE THE INFECTION. You CAN GET A GOOD FEEL FOR THAT. You CAN GET A GOOD FEEL FOR THAT IN ANIMAL MODELS.

In ANIMAL MODELS, THATS GOING TO BE INTERSPERSED THATS GOING TO BE INTERSPERSED AT THE SAME TIME THAT WERE AT THE SAME TIME THAT WERE TESTING WERE GOING. Try AND TESTING WERE GOING, TRY AND MAKE SURE WE DONT HAVE MAKE SURE WE DONT HAVE ENHANCEMENT, ENHANCEMENT, THATS, THE WORST POSSIBLE THING THATS, THE WORST POSSIBLE THING YOU CAN DO IS VACCINATE SOMEBODY YOU CAN DO IS VACCINATE SOMEBODY TO PREVENT INFECTION AND TO PREVENT INFECTION AND Actually MAKE THEM WORSE, ACTUALLY MAKE THEM WORSE, NEXT AND FINALLY ILL GET TO NEXT AND FINALLY ILL. Get TO YOUR QUESTION YOUR QUESTION. Finally, WITH REGARD TO, FINALLY, WITH REGARD TO THERAPIES, I MEAN WE KEEP THERAPIES, I MEAN WE KEEP GETTING ASKED ABOUT THERAPIES. Getting ASKED ABOUT THERAPIES, THERE IS A WHOLE MENU OF. There IS A WHOLE MENU OF THERAPIES THAT ARE GOING INTO THERAPIES THAT ARE GOING INTO CLINICAL TRIAL CLINICAL TRIAL, AS IVE TOLD YOU ALL AND AS IVE TOLD YOU ALL AND REPEATED AGAIN, THE BEST WAY TO REPEATED AGAIN THE BEST WAY TO GET THE BEST DRUG AS Quickly, AS GET THE BEST DRUG AS QUICKLY AS POSSIBLE IS TO DO A RANDOMIZED POSSIBLE IS TO DO A RANDOMIZED CONTROLLED TRIAL SO THAT YOU CONTROLLED TRIAL SO THAT YOU KNOW, IS IT SAFE AND IS IT KNOW, IS IT SAFE AND IS IT EFFECTIVE

Effective, IF ITS NOT EFFECTIVE, GET IT IF ITS NOT EFFECTIVE, GET IT OFF THE BOARD AND GO TO THE NEXT OFF THE BOARD AND GO TO THE NEXT THING THING. If IT IS EFFECTIVE, GET IT OUT IF IT IS EFFECTIVE, GET IT OUT TO THE PEOPLE THAT NEED IT TO THE PEOPLE THAT NEED IT. So YOURE GOING TO BE HEARING SO YOURE GOING TO BE HEARING OVER THE NEXT MONTH OR MORE OVER THE NEXT MONTH OR MORE ABOUT DIFFERENT DRUGS THAT ARE ABOUT DIFFERENT DRUGS THAT ARE GOING TO GO INTO THESE GOING TO GO INTO THESE RANDOMIZED CONTROL TRIALS.

Randomized CONTROL TRIALS AND I FEEL CONFIDENT KNOWING AND I FEEL CONFIDENT KNOWING ABOUT WHAT THIS VIRUS IS AND ABOUT WHAT THIS VIRUS IS AND WHAT WE CAN DO WITH IT THAT WE, WHAT WE CAN DO WITH IT, THAT WE WILL HAVE SOME SORT OF THERAPY, WILL HAVE Some SORT OF THERAPY THAT GIVE AT LEAST A PARTIAL, IF THAT, GIVE AT LEAST A PARTIAL, IF NOT A VERY GOOD PROTECTION IN